Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: J Immunol. 2011 Sep 2;187(7):3831–3839. doi: 10.4049/jimmunol.1003238

FIGURE 2.

FIGURE 2

CBLB502 attenuates leukocytic infiltration and tubular necrosis when given prior to imposition of renal ischemia. Groups of animals were given PBS or 0.5 μg CBLB502 i.v. 30 minutes prior to imposition of bilateral renal pedicle occlusion. A group of animals was also given 0.5 μg CBLB502 and then sham operated. After 45 minutes, the ischemic kidneys were reperfused and were harvested 7 days later. Prepared sections were stained with hematoxylin and representative sections are shown. Magnification, x100.